Jump to Main Content
- Kearney, Paul; Boniface, J Jay; Price, Nathan D; Hood, Leroy
- Current opinion in biotechnology 2018 v.51 pp. 123-129
- biomarkers; blood proteins; lung neoplasms; mass spectrometry; monitoring; phenotype; premature birth; proteomics; risk assessment
- ... Recently, the first two multiplexed tests using selective reaction monitoring (SRM-MS) mass spectrometry have entered clinical practice. Despite different areas of indication, risk stratification in lung cancer and preterm birth, they share multiple steps in their development strategies. Here we review these strategies and their implications for successful translation of biomarkers to clinical pra ...
- PubMed Central: